N1VO34:BVMF
Novo Nordisk Bdr
24,05 BRL
arrow_upward
+0,54%(+0,13) 1D
14 tet, 5:06:00 m.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për N1VO34...
Hap
23,98 BRL
I lartë
24,14 BRL
I ulët
23,80 BRL
Kapitalizimi i tregut
130,07 mld
Vëllimi mesatar
34,84 mijë
Vëllimi
3,65 mijë
Maksimumi 52-javor
42,43 BRL
Minimumi 52-javor
22,90 BRL
Aksionet në qarkullim
3,39 mld
Numri i punonjësve
67 mijë
Hap
23,98 BRL
I lartë
24,14 BRL
I ulët
23,80 BRL
Kapitalizimi i tregut
130,07 mld
Vëllimi mesatar
34,84 mijë
Vëllimi
3,65 mijë
Maksimumi 52-javor
42,43 BRL
Minimumi 52-javor
22,90 BRL
Aksionet në qarkullim
3,39 mld
Numri i punonjësve
67 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance
·
6 orë më parë
Is Novo Nordisk (NYSE:NVO) A Long Term Value Opportunity Now?
The Motley Fool
·
1 ditë më parë
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
TipRanks
·
1 ditë më parë
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
Yahoo Finance
·
2 ditë më parë
Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
Profili
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Rreth Novo Nordisk Bdr
Drejtori ekzekutivMaziar Mike Doustdar
Punonjësit66,7 mijë
Themeluar më1923
SeliaBagsværd, Capital Region of Denmark, Danimarkë
Sektori-
Uebsajtinovonordisk.com